Traders Purchase High Volume of Call Options on CVS Health (NYSE:CVS)

CVS Health Corporation (NYSE:CVS) was the target of unusually large options trading activity on Wednesday. Stock traders bought 23,271 call options on the company. This represents an increase of 33% compared to the typical daily volume of 17,551 call options.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Health Care Benefits outlook improves: CVS raised its outlook for the segment as stronger underlying trends, particularly in Medicare, are expected to support margin recovery despite continued medical-cost pressure. This is the most significant fundamental catalyst in the recent coverage. CVS’ Health Care Benefits Arm Shows Better Core Trends: What’s Ahead?
• Positive Sentiment: Valuation seen as attractive: Commentary from Jim Cramer characterized CVS as “insanely cheap,” suggesting that much of the company’s negative news may already be reflected in its valuation. This could encourage bargain-focused investors. Why CVS Is ‘Insanely Cheap,’ ON Semi a Laggard Catching Up, and Grail Too Expensive to Chase
• Positive Sentiment: Pharmacy access expansion: CVS opened its first pharmacy-focused location in the Boston area, providing medications, immunizations and pharmacist-led care in Roxbury. The initiative may strengthen community access and support pharmacy-service growth, although the near-term financial impact is likely limited. CVS Pharmacy celebrates opening of first pharmacy-focused location in Boston area
• Positive Sentiment: Vaccination demand opportunity: CVS reminded New York residents that MMR vaccines are available at more than 530 pharmacies and MinuteClinic locations amid a measles outbreak. The announcement reinforces CVS’s role in preventive care and could modestly increase pharmacy and clinic activity. CVS Health reminds New Yorkers that MMR vaccines are available statewide amid measles outbreak
• Neutral Sentiment: Analyst target remains above the market: Coverage cites a consensus price target of $107.24, indicating potential upside based on analyst expectations, though the target itself is not a new earnings or business announcement. CVS Health Corporation Stock Has Consensus Price Target of $107.24 According to Analysts
• Negative Sentiment: Dividend appeal trails UnitedHealth: A comparison for retirees highlights that CVS pays a substantially smaller annual dividend than UnitedHealth. This may limit enthusiasm among income-focused investors, even though CVS’s valuation and operating outlook appear more supportive. Better Dividend Stock for Retirees: CVS vs. UnitedHealth

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on CVS shares. Piper Sandler set a $112.00 target price on shares of CVS Health in a research note on Wednesday, September 9th. Argus lifted their price objective on CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a research report on Wednesday, August 19th. Truist Financial boosted their target price on CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Weiss Ratings raised CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 5th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a report on Thursday, October 1st. Twenty-two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $107.24.

Hedge Funds Weigh In On CVS Health

Several large investors have recently modified their holdings of the business. Rosenberg Matthew Hamilton grew its position in shares of CVS Health by 97.4% in the 3rd quarter. Rosenberg Matthew Hamilton now owns 1,775 shares of the pharmacy operator’s stock valued at $152,000 after buying an additional 876 shares during the last quarter. CapWealth Advisors LLC grew its position in shares of CVS Health by 1.4% during the 3rd quarter. CapWealth Advisors LLC now owns 344,416 shares of the pharmacy operator’s stock worth $29,513,000 after buying an additional 4,814 shares during the period. Argent Capital Management LLC boosted its stake in CVS Health by 50.4% during the third quarter. Argent Capital Management LLC now owns 238,110 shares of the pharmacy operator’s stock worth $20,404,000 after acquiring an additional 79,822 shares in the last quarter. MassMutual Private Wealth & Trust FSB grew its holdings in CVS Health by 21.0% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 5,003 shares of the pharmacy operator’s stock worth $429,000 after purchasing an additional 868 shares during the period. Finally, Boltwood Capital Management increased its stake in CVS Health by 5.0% in the third quarter. Boltwood Capital Management now owns 9,877 shares of the pharmacy operator’s stock valued at $846,000 after purchasing an additional 470 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Trading Up 1.6%

CVS Health stock traded up $1.36 during mid-day trading on Wednesday, hitting $87.79. The stock had a trading volume of 6,876,946 shares, compared to its average volume of 8,291,995. The stock has a 50-day simple moving average of $93.81 and a two-hundred day simple moving average of $92.19. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $112.28 billion, a PE ratio of 23.22, a P/E/G ratio of 0.85 and a beta of 0.60. CVS Health has a 12 month low of $69.51 and a 12 month high of $110.68.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. During the same period in the previous year, the business earned $1.81 EPS. CVS Health’s revenue for the quarter was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, sell-side analysts forecast that CVS Health will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 2nd. Investors of record on Thursday, October 22nd will be issued a $0.6650 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date is Thursday, October 22nd. CVS Health’s dividend payout ratio (DPR) is 70.37%.

CVS Health Company Profile

CVS Health Corp. is an integrated health care company that provides pharmacy, insurance and health services primarily in the United States. Its operations are designed to connect consumers, health plans, health care providers and pharmacy services across multiple points of care.

The company’s major businesses include CVS Pharmacy retail locations, prescription fulfillment and consumer health products; CVS Caremark, a pharmacy benefit management business; and Aetna, which offers health insurance products and related services for employers, individuals, government programs and other organizations.